These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22079818)

  • 21. Coexistence of hypothalamic and pituitary failure after successful pituitary surgery in Cushing's disease?
    Hermus AR; Pieters GF; Pesman GJ; Meijer E; Smals AG; Benraad TJ; Kloppenborg PW
    J Endocrinol Invest; 1987 Aug; 10(4):365-9. PubMed ID: 2824595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Harvey Cushing's early experience with the surgical treatment of head trauma.
    Kinsman M; Pendleton C; Quinones-Hinojosa A; Cohen-Gadol AA
    J Hist Neurosci; 2013; 22(1):96-115. PubMed ID: 23323535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harvey Cushing's surgical treatment of facial paralysis during his tenure at the Johns Hopkins Hospital.
    Pendleton C; Redett RJ; Quinones-Hinojosa A; Dorafshar AH
    Ann Plast Surg; 2013 Mar; 70(3):251-6. PubMed ID: 22868298
    [No Abstract]   [Full Text] [Related]  

  • 25. Failure of hypophysectomy to correct pituitary-dependent Cushing's disease in two patients.
    Cook DM; McCarthy PJ
    Arch Intern Med; 1988 Nov; 148(11):2497-500. PubMed ID: 3190383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Remission of pituitary-dependent Cushing's disease after removal of nonneoplastyic pituitary gland.
    Taylor HC; Velasco ME; Brodkey JS
    Arch Intern Med; 1980 Oct; 140(10):1366-8. PubMed ID: 6252859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Psychiatric disorders in patients with Cushing's disease before and after neurosurgery].
    Gnjidiae Z; Karloviae D; Buljan D; Malencia M; Kovak-Mufiae A; Kostanjsak L
    Turk Psikiyatri Derg; 2011; 22(1):35-9. PubMed ID: 21360354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Criteria for the surgical treatment of hypothalamo-hypophyseal-dependent Cushing's syndrome].
    Ozyol MB; Voigt KH; Fehm HL; Schmidt K; Herfarth C
    Langenbecks Arch Chir; 1976; Suppl():87-90. PubMed ID: 1031834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed lymphocytic infundibuloneurohypophysitis following successful transsphenoidal treatment of Cushing's disease.
    Kawaguchi T; Ikeda H; Fujimura M; Yoshimoto T; Tominaga T
    J Clin Neurosci; 2005 Apr; 12(3):320-3. PubMed ID: 15851095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harvey Cushing's Meningiomas text and the historical origin of resectability criteria for the anterior one third of the superior sagittal sinus.
    Shrivastava RK; Segal S; Camins MB; Sen C; Post KD
    J Neurosurg; 2003 Oct; 99(4):787-91. PubMed ID: 14567620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cushing's disease presenting with pituitary apoplexy.
    Chan D; Rong TC; Dalan R
    J Clin Neurosci; 2012 Nov; 19(11):1586-9. PubMed ID: 22658488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease.
    Patil CG; Veeravagu A; Prevedello DM; Katznelson L; Vance ML; Laws ER
    Neurosurgery; 2008 Aug; 63(2):266-70; discussion 270-1. PubMed ID: 18797356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cushing's disease. A review.
    Burch WM
    Arch Intern Med; 1985 Jun; 145(6):1106-11. PubMed ID: 3923962
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Making the "inoperable" tumors "operable": Harvey Cushing's contributions to the surgery of posterior fossa tumors.
    Malekpour M; Cohen-Gadol AA
    Neurosurg Focus; 2014 Apr; 36(4):E15. PubMed ID: 24684327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National trends, complications, and outcomes following transsphenoidal surgery for Cushing's disease from 1993 to 2002.
    Patil CG; Lad SP; Harsh GR; Laws ER; Boakye M
    Neurosurg Focus; 2007; 23(3):E7. PubMed ID: 17961019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cushing's disease resulting from pituitary corticotrophic microadenoma. Treatment results from transsphenoidal microsurgery and gamma knife radiosurgery.
    Laws ER; Reitmeyer M; Thapar K; Vance ML
    Neurochirurgie; 2002 May; 48(2-3 Pt 2):294-9. PubMed ID: 12058134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of hypercortisolism].
    Rosales C; Fierrard H; Bertagna X; Raffin-Sanson ML
    Rev Med Interne; 2008 Apr; 29(4):337-46. PubMed ID: 18226430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transsphenoidal surgery for Cushing's disease: a review of success rates, remission predictors, management of failed surgery, and Nelson's Syndrome.
    Kelly DF
    Neurosurg Focus; 2007; 23(3):E5. PubMed ID: 17961026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.